P-glycoprotein in blood-brain barrier endothelial cells: Interaction and oligomerization with caveolins

The influence of a caveolin-1 mutant on the function of P-glycoprotein

Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics

Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders. - Abstract - Europe PMC

Cells, Free Full-Text

The impact of α-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells

The ontogeny of P-glycoprotein in the developing human blood–brain barrier: implication for opioid toxicity in neonates

Full article: Caveolin-1: A tumor-promoting role in human cancer

JCI - A2A adenosine receptor modulates drug efflux transporter P- glycoprotein at the blood-brain barrier

Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics

Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand Obese mice with type 2 diabetes - ScienceDirect

The Role of P-Glycoprotein at the Blood–Brain Barrier in Neurological and Psychiatric Disease

Inhibition of IAAP photolabeling of P-gp by diazirine- CsA analogs.

High brain distribution of a new central nervous system drug candidate despite its P-glycoprotein-mediated efflux at the mouse blood-brain barrier - ScienceDirect

Caveolae-mediated transport at the injured blood–brain barrier as an underexplored pathway for central nervous system drug delivery - ScienceDirect

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders - ScienceDirect